The introduction of oligodimethyl siloxane segments at the termini of the alkyl tails has been employed to stabilize the bicontinuous cubic (Cub(bi)) phase of a chain-core-chain type molecule having a 1,2-bis(benzoyl)hydrazine central core with two chains attached at the 4' position of each benzoyl moiety. In this study, three silylated molecules, bis-C10Si2, bis-C10Si3, and C10Si2-C8C=C, were synthesized, where "CnSim" represents the number of carbon and silicon atoms in the chain and "bis" indicates the two chains being the same, whereas the last one is asymmetric with respect to the core. The phase behaviors were examined by using polarized optical microscopy, differential scanning calorimetry, and X-ray diffraction techniques. All three compounds form Cub(bi) phases and their syntheses were compared including their parent compound bis-C18. It was clearly revealed that the introduction of oligodimethyl siloxane segments effectively suppresses the crystallization at low temperatures, and as a result stabilizes the Cub(bi) phases, in an extreme case down to room temperature. The semi-quantitative analyses in terms of lattice constant and three-dimensional electron density map help us to better understand the self-assembly process in the Cub(bi) phases. The study also revealed that the introduction of oligodimethyl siloxane segments is not only an alternative for the hydrocarbon segment but also is able to provide a versatile design strategy for obtaining stable Cub(bi) phases.
By modifying the three molecular moieties, siloxane terminal, alkyl spacer, and aromatic core part, the molecular requirements for the formation of bicontinuous cubic phases are presented.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.